IDEX Corporation stock holds at $233 after Q2 2026 earnings beat

IDEX Corporation (US45167R1041) stock traded at $233.83 on the NYSE as of August 21, 2026, after the company reported Q2 2026 earnings per share of $2.32 that exceeded consensus estimates of $2.11.

Q2 2026 earnings beat and guidance

According to an earnings overview for IDEX, the company released its Q2 2026 results on July 29, 2026, posting earnings per share of $2.32 for the quarter, beating the average analyst estimate of $2.11 by $0.21. The same earnings summary notes that this performance supports full-year expectations for continued earnings growth. For investors, the $0.21 upside versus expectations provides a concrete signal that margin and volume drivers in the portfolio were stronger than modeled.

The same source shows that IDEX issued guidance for Q3 2026 earnings per share in a range of $2.200 to $2.250, slightly above the average analyst estimate of $2.19. This guidance band therefore brackets consensus at the lower end while leaving room for upside if operational execution remains solid. With full-year 2026 earnings projected at $8.26 per share based on current estimates, the Q3 guidance implies that the company expects to maintain quarterly earnings power close to the Q2 2026 level.

Stock performance, valuation and analyst view

Recent quote data show that IDEX stock closed at $233.83 on August 21, 2026, with the share price down $0.62, or 0.26 percent, from the prior close. The same overview reports a trailing earnings per share figure of $6.95, which translates to a price-to-earnings ratio of 33.64 at the $233.83 share price. That multiple indicates that the market is paying more than 33 times trailing earnings, a valuation level that looks aligned with expectations for mid to high single-digit earnings growth.

The earnings data source further indicates that IDEX earnings are expected to grow from $8.82 per share to $9.57 per share in the next year, representing an 8.50 percent increase. This projected step-up in earnings serves as a key justification for the current valuation, since it implies that the forward price-to-earnings multiple will moderate if the stock price holds and the company delivers on these forecasts. In addition, a separate coverage piece notes that the consensus full-year 2026 earnings estimate currently stands at $8.82 per share, while one research provider recently highlighted a revised outlook that is less optimistic than the consensus, suggesting some debate among analysts on the pace of earnings expansion.

An institutional-ownership update on August 21, 2026, indicates that several large asset managers have recently disclosed new or increased positions in IDEX shares, including reported holdings totaling hundreds of thousands of shares in recent regulatory filings. One such filing reflects a new investment and describes IDEX stock as trading at $233.83 at the time of the report, framing the valuation discussion for long-term investors. Another filing the same day details a purchase of 426,901 shares and also references the $233.83 opening price, underscoring the fact that large shareholders are willing to add exposure at this level.

52-week range and market capitalization context

A market-data snapshot dated August 21, 2026 shows that IDEX shares traded at $233.83 at the start of trading on the NYSE, giving the company a market capitalization of $17.24 billion based on that price level. The same market overview reports that the stock remains within a 52-week trading range of $158.19 to $243.80. This places the latest $233.83 price roughly $10 below the 52-week high while standing more than $75 above the 52-week low, indicating that the shares are trading in the upper segment of their one-year band.

The relationship between the current price and the 52-week extremes offers a simple way to frame risk and reward. At $233.83 versus the 52-week low of $158.19, IDEX shares are up more than $75 compared with the trough, reflecting significant recovery and growth in investor confidence over the past year. Meanwhile, the roughly $10 difference between the current price and the 52-week high of $243.80 highlights that momentum is intact but that the stock has not yet broken to a new high, leaving room for both upside and consolidation depending on how upcoming quarters unfold.

The same market-data commentary also notes that the price change on August 21, 2026, amounts to a $0.62 move, corresponding to 0.26 percent, which indicates a relatively muted daily fluctuation. For investors, this small percentage move, combined with a high absolute share price and a multibillion-dollar market capitalization, suggests that short-term volatility remains controlled even as the company navigates a higher valuation regime tied to its earnings outperformance.

Representative product and business profile

IDEX Corporation is widely known as a diversified industrial company whose portfolio includes specialized engineered products such as fluid and metering technologies, health and science instruments, and fire and safety equipment like the Jaws of Life rescue tools. The latest earnings and guidance figures for Q2 2026 and Q3 2026 highlight how these niche, high-value products can support both stable revenue streams and robust profitability across cycles. While the detailed segment breakdown is not listed in the recent summary sources, the fact that IDEX could deliver $2.32 in earnings per share in Q2 2026 and guide to up to $2.25 for Q3 2026 suggests that its mix of critical infrastructure and safety products continues to generate strong demand.

For many investors, the Jaws of Life product line offers a tangible example of the company’s role in essential applications. These hydraulic rescue tools are used by emergency responders to extricate passengers from vehicles and other confined spaces after serious accidents. The value proposition of such equipment is not primarily cyclical, which can help stabilize orders even when macroeconomic conditions soften. The capacity of these tools to save lives supports resilient demand from municipalities and safety-conscious buyers, and the associated consumables and maintenance services can contribute recurring revenue over time.

IDEX stock level as of the latest close

As of August 21, 2026, the most recent completed trading session shows IDEX Corporation stock closing at $233.83 on the NYSE in U.S. dollars. This closing level sits within the 52-week range of $158.19 to $243.80 cited in the latest market-data snapshot and corresponds to a market capitalization of $17.24 billion at that price point, providing investors with a clear picture of how the current valuation aligns with the company’s earnings power and growth expectations.

Fact box

Company: IDEX Corporation Inc.
ISIN: US45167R1041
Ticker: IEX
Exchange: NYSE
Price (as of August 21, 2026, 3:58 p.m. ET): $233.83 USD
Market cap: $17.24 billion (as of August 21, 2026)
Sector / Industry: Industrials / Industrial machinery
Index membership: S&P 500